COVID-19 vaccine review starts Dec. 10
Duration of process is not yet known
Share
Tweet
Last updated 12/6/2020 at 8:38pm
Courtesy of pixabay.com
The FDA is considering a vaccine to combat COVID-19. The duration of the review is not yet known but will be open to the public
The FDA is poised to consider a vaccine for COVID-19 on Dec. 10, a medical innovation with the potential power to end the pandemic six to nine months from the approval date.
The duration of that review is not yet known, but the meeting will be open and transparent, and livestreamed for public viewing.
"The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want to assure the American people that the FDA's process and evaluation of the data for a potential COVID-19 vaccine will be as open and transparent as possible," said FDA...
For access to this article please
sign in or
subscribe.
Reader Comments(0)